BioStorage Technologies to strategically expand into Asia Pacific

Tuesday, July 17, 2012 12:09 PM

Indianapolis-based BioStorage Technologies, a provider of comprehensive sample management solutions for the bioscience industry, is expanding its services to the Asia Pacific region. The expansion includes the appointment of Jason Huang as general manager of Asia Pacific. 

Headquartered in Singapore and operating in China as a wholly owned foreign enterprise, BioStorage Technologies Asia Pacific will provide technical consulting in addition to sample management. Huang will be responsible for overseeing and managing operations, identifying and developing new services and driving overall business development and services growth in the region.

Born and raised in Singapore, Huang has worked in regulated environments in China, Singapore and other countries in Asia Pacific, including with several companies to manage and develop global strategic plans. Most recently, Huang worked at Prima Limited in Singapore and was a consultant with UMS Advisory in the U.S.

BioStorage Technologies stores and manages research samples from the world’s largest biopharmaceutical companies and CROs. As a pioneer of Good Storage Practices (GSP), the company is committed to ensuring sample integrity throughout the complete sample life-cycle. Utilizing ISISS, the industry’s most advanced virtual sample management and web-based tracking tool, BioStorage Technologies provides a complete FDA-compliant audit trail annotated on every sample.

 

Share:          
CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs